Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients

INTRODUCTION: Several new medications are now available for immunosuppression in the kidney transplant field. Tacrolimus and mycophenolate mofetil were first introduced for immunosuppression in renal transplantation in the mid 1990s. Since then, the combination of tacrolimus and mycophenolate mofeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, P, Shah, G, Chhabra, D, Gallon, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108777/
https://www.ncbi.nlm.nih.gov/pubmed/21694936
_version_ 1782205373032169472
author Dalal, P
Shah, G
Chhabra, D
Gallon, Lorenzo
author_facet Dalal, P
Shah, G
Chhabra, D
Gallon, Lorenzo
author_sort Dalal, P
collection PubMed
description INTRODUCTION: Several new medications are now available for immunosuppression in the kidney transplant field. Tacrolimus and mycophenolate mofetil were first introduced for immunosuppression in renal transplantation in the mid 1990s. Since then, the combination of tacrolimus and mycophenolate mofetil has been evaluated in numerous clinical trials. The outcomes of these trials have varied due to differences in induction and/or maintenance therapy, drug dosing and monitoring protocols, and study design. The aim of this review is to analyze the literature critically and to provide an overview of tacrolimus and mycophenolate mofetil combination therapy in renal transplantation.
format Online
Article
Text
id pubmed-3108777
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31087772011-06-21 Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients Dalal, P Shah, G Chhabra, D Gallon, Lorenzo Int J Nephrol Renovasc Dis Review INTRODUCTION: Several new medications are now available for immunosuppression in the kidney transplant field. Tacrolimus and mycophenolate mofetil were first introduced for immunosuppression in renal transplantation in the mid 1990s. Since then, the combination of tacrolimus and mycophenolate mofetil has been evaluated in numerous clinical trials. The outcomes of these trials have varied due to differences in induction and/or maintenance therapy, drug dosing and monitoring protocols, and study design. The aim of this review is to analyze the literature critically and to provide an overview of tacrolimus and mycophenolate mofetil combination therapy in renal transplantation. Dove Medical Press 2010-08-04 /pmc/articles/PMC3108777/ /pubmed/21694936 Text en © 2010 Dalal et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Dalal, P
Shah, G
Chhabra, D
Gallon, Lorenzo
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
title Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
title_full Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
title_fullStr Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
title_full_unstemmed Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
title_short Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
title_sort role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108777/
https://www.ncbi.nlm.nih.gov/pubmed/21694936
work_keys_str_mv AT dalalp roleoftacrolimuscombinationtherapywithmycophenolatemofetilinthepreventionoforganrejectioninkidneytransplantpatients
AT shahg roleoftacrolimuscombinationtherapywithmycophenolatemofetilinthepreventionoforganrejectioninkidneytransplantpatients
AT chhabrad roleoftacrolimuscombinationtherapywithmycophenolatemofetilinthepreventionoforganrejectioninkidneytransplantpatients
AT gallonlorenzo roleoftacrolimuscombinationtherapywithmycophenolatemofetilinthepreventionoforganrejectioninkidneytransplantpatients

Ejemplares similares